Travere Therapeutics
Retrophin - Discovery and development of drugs to treat catastrophic diseases.
Launch date
Employees
Market cap
$964m
Enterprise valuation
$1.0b (Public information from Sep 2024)
Share price
$15.06 TVTX
San Diego California (HQ)
Authorizing premium user...